Company Registration 14 September 2026
Gland Pharma Fined ₹1.40 Lakh for Director Norm Breach
Gland Pharma has been penalised with a fine of ₹1.40 lakh after a technical breach of director norms was identified. The company promptly informed both BSE Limited and the National Stock Exchange of India, with Company Secretary Sampath Kumar Pallerlamudi overseeing the compliance filing. The penalty underscores heightened regulatory scrutiny on governance standards within Indian listed firms, urging stricter adherence to director appointment and reporting rules.
- Fine imposed: Gland Pharma must pay ₹1.40 lakh for a technical breach of director norms.
- Regulatory notice: The company filed the intimation with BSE Limited and the National Stock Exchange of India.
- Compliance officer: Company Secretary & Compliance Officer Sampath Kumar Pallerlamudi handled the filing.
For full details, see the original report here.
Need help understanding this update?
Connect with our domain experts instantly via WhatsApp for customized legal guidance.